The stable outlook reflects S&P Global Ratings’ expectation that Amgen’s revenue and EBITDA will remain stable despite patent ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take ...

Specialty drugs are increasingly entering general medicine. Experts at Asembia’s AXS Summit say the trend will put a premium ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

"We are thrilled to welcome Jason to BlossomHill and look forward to him helping the company make transformational leaps ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Shares of Regeneron Pharmaceuticals Inc. slipped 3.63% to $527.78 Friday, on what proved to be an all-around poor trading ...

The Dow Jones Industrial Average is trading down Friday afternoon with shares of UnitedHealth and IBM seeing the biggest losses for the price-weighted average. The Dow was most recently trading 217 ...